Clinical Study of DA-020 for the Treatment of Chemotherapy Induced Alopecia
Trial statusNot yet recruiting
Trial phasePhase 1, Phase 2
Trial typeInterventional
Biological sexFemale
Age18-65
SponsorApplied Biology, Inc.
About this trial
Clinical Study of DA-020 as a Treatment for Chemotherapy Induced Alopecia
Eligibility criteria
Qualifiers
Diagnosed with stage I or stage II breast cancer
Scheduled but not begun, at least 4 cycles of taxane and/or anthracycline-based chemotherapy.
Ages 18-65
Able to give informed consent
Disqualifiers
Resting blood pressure outside the range of 105-140/ 55-99
Uncontrolled or severe hypertension
Female pattern hair loss or hair loss disorder
Folliculitis
Trial design
Treatments tested in this trial
- DA-020
- Placebo
- DA-020 and Hyperforin
Treatment groups
60 Participants
are divided into 3 treatment groupsSponsors and collaborators
Applied Biology, Inc.
Lead sponsor
Daniel Alain, Inc.
Collaborator
Follea International Limited
Collaborator
Source ClinicalTrials.gov